GRAL Grail
- 16.160
- -1.290-7.39%
- 16.320
- +0.160+0.99%
Grail News
Express News | Wheels up Announces Gregory Summe to Join Board of Directors
Press Release: Wheels Up Announces Gregory Summe to Join Board of Directors
GRAIL to Announce Second Quarter 2024 Financial Results
Here's Why You Should Add Illumina (ILMN) to Your Portfolio
The Race to Develop the 'Holy Grail' of Weight-loss Drugs
Stock Warnings: Sunpower, Domino's, and Grail
Grail Announces First Patients Enrolled in REACH Cancer Trial
Express News | GRAIL Shares Are Trading Lower. The Company Announced That the First Participant Has Been Enrolled in the REACH/Galleri-Medicare Study at Community Health Network
Express News | Grail Inc - Medicare to Cover Costs for Galleri Study Participants
Express News | Grail Announces First Participant Enrolled in Reach Study Evaluating Clinical Impact of Galleri® Multi-Cancer Early Detection (Mced) Test in the Medicare Population
Dow, S&P 500 Hit Closing Records as Markets Weigh Retail Sales Report, Earnings
GRAIL Shares Are Trading Higher After the Company Provided an Update on the PATHFINDER 2 and NHS-Galleri Registrational Clinical Trials Evaluating the Galleri Multi-cancer Early Detection Test.
Express News | GRAIL Shares Are Trading Higher After the Company Provided an Update on the PATHFINDER 2 and NHS-Galleri Registrational Clinical Trials Evaluating the Galleri Multi-cancer Early Detection Test
Sector Update: Health Care Stocks Edge Higher Premarket Monday
The New Holy Grail for Weight-Loss Drugs Is Sleep Apnea -- WSJ
Grail Completes Enrollment in US Study for Cancer Early-Detection Device
Express News | Grail Inc - Final Results From Nhs-Galleri Trial Expected in 2026
Express News | Grail Advances the Galleri® Registrational Clinical Trial Program
Illumina Takes a $1.47 Billion Charge Related to Its GRAIL Spinoff
Gene-sequencing Group Illumina Sees $1.47 Bn Q2 Impairment Charge Linked to Grail
Analysis
Price Target
No Data
